Preface |
|
ix | |
Acknowledgements |
|
xi | |
|
The value of fine needle aspiration |
|
|
1 | (10) |
|
|
1 | (1) |
|
|
2 | (1) |
|
Advantages and disadvantages |
|
|
3 | (4) |
|
|
7 | (1) |
|
|
7 | (4) |
|
|
11 | (8) |
|
|
12 | (2) |
|
|
14 | (1) |
|
Mammographic abnormalities |
|
|
15 | (4) |
|
|
19 | (14) |
|
|
19 | (1) |
|
|
20 | (1) |
|
|
20 | (3) |
|
|
23 | (4) |
|
|
27 | (2) |
|
Naked eye appearance of the smear |
|
|
29 | (1) |
|
|
30 | (1) |
|
|
30 | (3) |
|
|
33 | (6) |
|
|
34 | (1) |
|
|
35 | (1) |
|
|
36 | (1) |
|
|
37 | (2) |
|
|
39 | (8) |
|
|
40 | (1) |
|
|
40 | (1) |
|
|
41 | (1) |
|
|
41 | (1) |
|
|
42 | (1) |
|
|
43 | (1) |
|
|
43 | (1) |
|
|
43 | (1) |
|
|
44 | (3) |
|
|
47 | (6) |
|
|
47 | (1) |
|
|
48 | (1) |
|
|
48 | (1) |
|
|
48 | (1) |
|
|
49 | (1) |
|
|
50 | (1) |
|
|
50 | (1) |
|
Overstaining and understaining |
|
|
50 | (1) |
|
Contamination by cells from other specimens |
|
|
51 | (2) |
|
|
53 | (8) |
|
Sampling problems leading to false-negative diagnoses |
|
|
55 | (1) |
|
Sampling problems leading to false-positive diagnoses |
|
|
56 | (2) |
|
Interpretive problems leading to false-negative diagnoses |
|
|
58 | (1) |
|
Interpretive problems leading to false-positive diagnoses |
|
|
58 | (3) |
|
|
61 | (4) |
|
|
61 | (1) |
|
|
62 | (1) |
|
|
62 | (1) |
|
|
62 | (1) |
|
|
63 | (2) |
|
|
65 | (14) |
|
|
66 | (1) |
|
|
67 | (3) |
|
|
70 | (2) |
|
|
72 | (1) |
|
|
73 | (3) |
|
|
76 | (3) |
|
|
79 | (10) |
|
Prepubertal and involutionary appearances |
|
|
80 | (1) |
|
|
81 | (4) |
|
|
85 | (1) |
|
Columnar cell alteration of lobules (Blunt duct adenosis) |
|
|
86 | (3) |
|
Cytology of the male breast |
|
|
89 | (6) |
|
|
89 | (2) |
|
|
91 | (4) |
|
Fibrocystic change of the breast |
|
|
95 | (8) |
|
|
95 | (4) |
|
|
99 | (1) |
|
|
100 | (3) |
|
Miscellaneous non-neoplastic conditions |
|
|
103 | (12) |
|
|
103 | (2) |
|
|
105 | (2) |
|
|
107 | (2) |
|
|
109 | (2) |
|
|
111 | (2) |
|
|
113 | (2) |
|
Fibroadenoma and related lesions |
|
|
115 | (14) |
|
Fibroadenomatoid hyperplasia |
|
|
116 | (1) |
|
|
116 | (6) |
|
|
122 | (2) |
|
|
124 | (1) |
|
Lactating adenoma (lactating nodule) |
|
|
124 | (1) |
|
|
125 | (4) |
|
|
129 | (8) |
|
|
129 | (2) |
|
Nodular sclerosing adenosis, adenosis tumour |
|
|
131 | (1) |
|
|
132 | (1) |
|
Radial scar, complex sclerosing lesions |
|
|
132 | (5) |
|
Papilloma and related lesions |
|
|
137 | (6) |
|
|
137 | (2) |
|
|
139 | (1) |
|
|
140 | (1) |
|
|
141 | (2) |
|
|
143 | (8) |
|
|
143 | (2) |
|
|
145 | (1) |
|
|
146 | (5) |
|
|
151 | (6) |
|
|
151 | (1) |
|
|
152 | (2) |
|
|
154 | (1) |
|
|
155 | (2) |
|
|
157 | (16) |
|
|
158 | (10) |
|
|
158 | (4) |
|
|
162 | (2) |
|
|
164 | (4) |
|
Lobular carcinoma in situ |
|
|
168 | (5) |
|
|
173 | (20) |
|
Invasive `ductal' carcinoma (NST) |
|
|
174 | (3) |
|
|
177 | (10) |
|
Invasive lobular carcinoma |
|
|
187 | (6) |
|
Uncommon types of invasive carcinoma |
|
|
193 | (12) |
|
|
193 | (1) |
|
Invasive cribriform carcinoma |
|
|
194 | (1) |
|
Invasive papillary carcinoma |
|
|
195 | (1) |
|
|
196 | (1) |
|
|
197 | (1) |
|
|
198 | (1) |
|
|
198 | (1) |
|
|
199 | (2) |
|
Carcinoma with osteoclast-like giant cells |
|
|
201 | (1) |
|
|
202 | (3) |
|
Prognostic features and research |
|
|
205 | (10) |
|
Cytological grading of breast carcinoma |
|
|
205 | (3) |
|
|
|
208 | (1) |
|
|
208 | (1) |
|
Receptors and biological markers |
|
|
209 | (3) |
|
|
212 | (1) |
|
|
212 | (1) |
|
|
212 | (1) |
|
|
212 | (3) |
|
Cytology of the irradiated breast |
|
|
215 | (6) |
|
|
221 | (10) |
|
|
221 | (5) |
|
|
221 | (2) |
|
|
223 | (1) |
|
|
224 | (1) |
|
|
224 | (1) |
|
|
225 | (1) |
|
|
225 | (1) |
|
|
225 | (1) |
|
|
225 | (1) |
|
|
226 | (5) |
|
Haemangiosarcoma/lymphangiosarcoma |
|
|
226 | (1) |
|
Malignant fibrous histiocytoma |
|
|
227 | (1) |
|
|
227 | (1) |
|
|
228 | (1) |
|
Primary osteogenic sarcoma |
|
|
228 | (1) |
|
|
228 | (1) |
|
|
229 | (1) |
|
|
229 | (2) |
|
|
231 | (10) |
|
|
231 | (3) |
|
|
234 | (2) |
|
|
236 | (1) |
|
|
237 | (1) |
|
|
238 | (1) |
|
|
238 | (3) |
|
Audit of statistical data and quality assurance |
|
|
241 | (12) |
|
|
243 | (3) |
|
Interpretation of results |
|
|
246 | (1) |
|
Analysis of results in the literature |
|
|
247 | (2) |
|
Results from the UK breast-screening programme |
|
|
249 | (4) |
Index |
|
253 | |